Disc Medicine (IRON) Capital Expenditures (2021 - 2025)
Disc Medicine (IRON) reported Capital Expenditures of $20000.0 for Q4 2025, down 95.55% year-over-year from $449000.0 in Q4 2024, and down 23.08% quarter-over-quarter from $26000.0 in Q3 2025.
Disc Medicine (IRON) Capital Expenditures (2021 - 2025) Analysis & Trends
Disc Medicine (IRON) has 5 years of Capital Expenditures data on file, last reported at $20000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at $20000.0, down 95.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $82000.0 (down 93.64% YoY), and the FY2025 annual result was $933000.0, up 84.75% from the prior year.
- Capital Expenditures retreated to $20000.0 in Q4 2025 per IRON's latest filing, from $26000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $851000.0 in Q1 2025 and troughed at -$51000.0 in Q4 2021.
- A 5-year average of $95705.9 and a median of $20000.0 in 2022 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 14866.67% in 2024 and fell as far as 125.0% in 2024.
- A 5-year view of Capital Expenditures shows it stood at -$51000.0 in 2021, then soared by 123.53% to $12000.0 in 2022, then sank by 75.0% to $3000.0 in 2023, then soared by 14866.67% to $449000.0 in 2024, then sank by 95.55% to $20000.0 in 2025.
- Business Quant data shows IRON's Capital Expenditures at $20000.0 in Q4 2025, $26000.0 in Q3 2025, and $36000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 851,000.00 |
| Mar 31, 2025 | 851,000.00 |
| Dec 31, 2024 | 449,000.00 |
| Dec 31, 2024 | 449,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Sep 30, 2023 | 45,000.00 |